Advertisement
Singapore markets closed
  • Straits Times Index

    3,280.10
    -7.65 (-0.23%)
     
  • Nikkei

    37,934.76
    +306.28 (+0.81%)
     
  • Hang Seng

    17,651.15
    +366.61 (+2.12%)
     
  • FTSE 100

    8,122.92
    +44.06 (+0.55%)
     
  • Bitcoin USD

    64,066.89
    +678.76 (+1.07%)
     
  • CMC Crypto 200

    1,389.41
    -7.13 (-0.51%)
     
  • S&P 500

    5,048.42
    -23.21 (-0.46%)
     
  • Dow

    38,085.80
    -375.12 (-0.98%)
     
  • Nasdaq

    15,611.76
    -100.99 (-0.64%)
     
  • Gold

    2,356.10
    +13.60 (+0.58%)
     
  • Crude Oil

    84.23
    +0.66 (+0.79%)
     
  • 10-Yr Bond

    4.6710
    -0.0350 (-0.74%)
     
  • FTSE Bursa Malaysia

    1,575.16
    +5.91 (+0.38%)
     
  • Jakarta Composite Index

    7,036.08
    -119.22 (-1.67%)
     
  • PSE Index

    6,628.75
    +53.87 (+0.82%)
     

Stocks To Watch: Intra-Cellular Therapies Sees Relative Strength Rating Rise To 93

Stocks To Watch: Intra-Cellular Therapies Sees Relative Strength Rating Rise To 93

Intra-Cellular Therapies had its Relative Strength (RS) Rating upgraded from 87 to 93 Tuesday. When looking for the best stocks to buy and watch, one factor to watch closely is relative price strength. This unique rating identifies market leadership by showing how a stock's price movement over the last 52 weeks compares to that of the other stocks in our database.